HomeInsightsMarket Capitalization

Market Capitalization of Ajanta Pharma Ltd

Market Capitalization of Ajanta Pharma Ltd

stocks purchased

₹ 1.1 Cr

Volume transacted

stocks purchased

3.5 K

stocks traded

Last Updated time: 05 Nov 12:24 PM

Image

Ajanta Pharma Ltd

NSE: AJANTPHARM

MARKETCAP

37426.79 crore

Last updated on: Nov 04, 2024

Key Highlights

  • The Market Cap of Ajanta Pharma Ltd is ₹ 37426 crore as of 04 Nov 24.
  • The Market Cap of Ajanta Pharma Ltd changed from ₹ 8990 crore on March 2019 to ₹ 28181 crore on March 2024 . This represents a CAGR of 20.97% over 6 years. .
  • The Latest Trading Price of Ajanta Pharma Ltd is ₹ 3065 as of 05 Nov 12:16.

Historical Market Cap of Ajanta Pharma Ltd

No data available

* All values are in crore

Company Fundamentals for Ajanta Pharma Ltd

No data available

Image

Ajanta Pharma Ltd

NSE: AJANTPHARM

PRICE

3065

68.75 (2.29%)

stock direction

Last updated on: Nov 05 12:16 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Ajanta Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20242996.25
01 Nov 20243079.15
31 Oct 20243071.85
30 Oct 20242994.1
29 Oct 20242925
28 Oct 20242921.1
25 Oct 20242970.9
24 Oct 20242972.3
23 Oct 20242948
22 Oct 20242977.8

SWOT Analysis Of Ajanta Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ajanta Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Ajanta Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Ajanta Pharma Ltd

No data available

Historical P/E Ratio of Ajanta Pharma Ltd

No data available

* All values are in %

Historical Revenue of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Ajanta Pharma Ltd

No data available

* All values are in %

About Ajanta Pharma Ltd

  • Ajanta Pharma is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa.
  • The Company is involved in development, manufacturing and marketing of marketing of quality finished dosages in domestic and international markets.
  • It produces a comprehensive range of specialty products targeting different therapeutic segments.
  • It has strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company's business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
  • The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia.

Ajanta Pharma Ltd News Hub

News

Ajanta Pharma Ltd spurts 2.75%, rises for third straight session

Ajanta Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 3079...

Read more

31 Oct 202413:05

News

Ajanta Pharma gains after Q2 PAT jumps 11% YoY to Rs 216 cr; declares dividend of Rs 28/ share

Profit before tax gained 5.18% YoY to Rs 290.24 crore in Q2 FY25. EBITDA stood at Rs 311 c...

Read more

29 Oct 202412:27

News

Board of Ajanta Pharma recommends First Interim Dividend

Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on ...

Read more

28 Oct 202416:20

News

Ajanta Pharma Ltd eases for fifth straight session

Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2...

Read more

23 Oct 202413:35

News

Ajanta Pharma to hold board meeting

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 28 October 2...

Read more

17 Oct 202417:15

News

Ajanta Pharma hits record high after Q1 PAT rises 19% YoY to Rs 246 cr

Profit before tax increased 19.73% YoY to Rs 322.12 crore in Q1 FY25. EBITDA stood at Rs 3...

Read more

30 Jul 202415:46

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Ajanta Pharma Ltd Market Cap

What is the market cap of Ajanta Pharma Ltd?

As of November 5, 2024, Ajanta Pharma Ltd has a market capitalization of ₹37426.79, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Ajanta Pharma Ltd's market capitalization?

Ajanta Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Ajanta Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Ajanta Pharma Ltd's market capitalization change?

Ajanta Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*